VIDANT ROANOKE CHOWAN HOSPITAL — History
CCN 340099 | 3-year financial timeline | COVID resilience: 36/100
🛡️ Public data only — no PHI permitted on this instance.
$89M
Latest Revenue (FY2022)
+1.6%
Revenue CAGR (3yr)
-12.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $86M | $92M | $89M | -3.9% | +1.6% |
| Operating Expenses | $88M | $93M | $99M | +7.2% | +6.3% |
| Operating Margin | -2.6% | -0.6% | -12.2% | -1964.5% | +0.0% |
| Net Income | $-2M | $-1M | $-11M | -1883.7% | +0.0% |
| Licensed Beds | 70 | 70 | 70 | +0.0% | +0.0% |
| Total Patient Days | 14,136 | 15,154 | 14,917 | -1.6% | +2.7% |
| Medicare Day % | 48% | 44% | 38% | -12.8% | -10.6% |
| Medicaid Day % | 15% | 12% | 6% | -52.8% | -38.6% |
COVID Impact & Recovery
Resilience Score: 36/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +3.2% ($86M → $89M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.6%
This Hospital
+7.6%
State Avg
Latest Margin
-12.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $90M | -17.1% |
| FY2024 (proj) | $91M | -21.9% |
| FY2025 (proj) | $93M | -26.7% |